Effects of Caffeine on Anxiety, Emotional Processing, Approach-avoidance Behavior, and Interoception in Panic Disorder
Panic Disorder, Healthy
About this trial
This is an interventional basic science trial for Panic Disorder
Eligibility Criteria
Inclusion Criteria:
Panic disorder group: Primary diagnosis of panic disorder.
Healthy control group: No current or history of psychiatric disorders.
All participants (Panic disorder and healthy): Weekly caffeine consumption ≤ 300 mg.
Exclusion Criteria:
History of severe psychiatric disorder (e.g. schizophrenia). Somatic or neurological conditions (e.g. hypertension and heart condition). Ongoing treatment with psychotropic medication or treatment with psychotropic medication which has been discontinued within 2 months. Other ongoing treatments that may confound the results. Current drug or alcohol abuse/dependency. Habitual nicotine use. Uncorrected visual or hearing impairment. Pregnancy.
Sites / Locations
- Uppsala university, Department of Medical Sciences, Psychiatry
Arms of the Study
Arm 1
Arm 2
Other
Other
Panic disorder
Healthy controls
Participants will be randomized to start with either the caffeine condition or placebo condition. Participants will complete session 2 with the other condition (condition not allocated to in session 1).
Participants will be randomized to start with either the caffeine condition or placebo condition. Participants will complete session 2 with the other condition (condition not allocated to in session 1).